Trial intelligence / Profile preview

ASPIRE: Aliskiren in Post-MI Patients

NCT00414609Phase 3Completed

Sponsor
Novartis
Start
Dec 2006
Primary completion
Sep 2009
Modality
Small Molecules
Countries
23
01

Overview

A Phase 3 trial of aliskiren in myocardial infarction (MI), sponsored by Novartis. Started Dec 2006; status: completed.

02

Drugs

aliskiren
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT00414609.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00414609.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call